These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28533020)

  • 21. Anti-incretin effect: The other face of Janus in human glucose homeostasis.
    Karras SN; Koufakis T; Mustafa OG; Kotsa K
    Obes Rev; 2019 Nov; 20(11):1597-1607. PubMed ID: 31347774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of peptide YY in regulating glucose homeostasis.
    Boey D; Sainsbury A; Herzog H
    Peptides; 2007 Feb; 28(2):390-5. PubMed ID: 17210210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bariatric surgery - time to replace with GLP-1?
    Webb DL; Abrahamsson N; Sundbom M; Hellström PM
    Scand J Gastroenterol; 2017; 52(6-7):635-640. PubMed ID: 28276830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic control after metabolic surgery: a Granger causality and graph analysis.
    Previti E; Salinari S; Bertuzzi A; Capristo E; Bornstein S; Mingrone G
    Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E622-E630. PubMed ID: 28698280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretins, amylin and other gut-brain axis hormones in children with coeliac disease.
    Papastamataki M; Papassotiriou I; Bartzeliotou A; Vazeou A; Roma E; Chrousos GP; Kanaka-Gantenbein C
    Eur J Clin Invest; 2014 Jan; 44(1):74-82. PubMed ID: 24151959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PYY transgenic mice are protected against diet-induced and genetic obesity.
    Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The satiety hormone peptide YY as a regulator of appetite.
    Vincent RP; le Roux CW
    J Clin Pathol; 2008 May; 61(5):548-52. PubMed ID: 18441153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PYY, a Therapeutic Option for Type 2 Diabetes?
    Guida C; Ramracheya R
    Clin Med Insights Endocrinol Diabetes; 2020; 13():1179551419892985. PubMed ID: 32030069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bariatric surgery and the gut-brain communication--the state of the art three years later.
    Diniz Mde F; Azeredo Passos VM; Diniz MT
    Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of peptide YY in integrative gut physiology and potential role in obesity.
    Grudell AB; Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):52-7. PubMed ID: 17940420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes.
    Lafferty RA; Flatt PR; Irwin N
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):253-261. PubMed ID: 33395088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R.
    Choong YS; Lim YY; Soong JX; Savoo N; Guida C; Rhyman L; Ramracheya R; Ramasami P
    Hormones (Athens); 2021 Sep; 20(3):557-569. PubMed ID: 33782920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.
    Chaudhry S; Bernardes M; Harris PE; Maffei A
    Minerva Endocrinol; 2016 Mar; 41(1):43-56. PubMed ID: 26505694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival.
    Sam AH; Gunner DJ; King A; Persaud SJ; Brooks L; Hostomska K; Ford HE; Liu B; Ghatei MA; Bloom SR; Bewick GA
    Gastroenterology; 2012 Aug; 143(2):459-68. PubMed ID: 22562022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of diabetes surgery on gut hormones and incretins.
    Papamargaritis D; Miras AD; le Roux CW
    Nutr Hosp; 2013 Mar; 28 Suppl 2():95-103. PubMed ID: 23834052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bariatric surgeries: beyond restriction and malabsorption.
    Sandoval D
    Int J Obes (Lond); 2011 Sep; 35 Suppl 3():S45-9. PubMed ID: 21912388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A perspective on metabolic surgery from a gastroenterologist.
    Syu YF; Inui A; Chen CY
    J Pharmacol Sci; 2017 Feb; 133(2):61-64. PubMed ID: 28237320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.